Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020311857 |
id |
doaj-2f6cc72f06ae4c6cac69dcac1af79c5c |
---|---|
record_format |
Article |
spelling |
doaj-2f6cc72f06ae4c6cac69dcac1af79c5c2021-05-04T07:24:50ZengElsevierJournal of Virus Eradication2055-66402016-05-01239Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trialErwann P. Loret0Albert Darque1Elvenn A. Loret2Corinne Nicolino-Brunet3Sophie Morange4Elisabeth Castagnier5Josiane Casanova6Christine Caloustian7Charléric Bornet8Julie Coussirou9Jihen Bousseta10Bertrand Dussol11Isabelle Ravaux12ETRAV Laboratory CNRS/AMU, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, France; La Conception University Hospital, Dispensary, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, Francehttp://www.sciencedirect.com/science/article/pii/S2055664020311857 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Erwann P. Loret Albert Darque Elvenn A. Loret Corinne Nicolino-Brunet Sophie Morange Elisabeth Castagnier Josiane Casanova Christine Caloustian Charléric Bornet Julie Coussirou Jihen Bousseta Bertrand Dussol Isabelle Ravaux |
spellingShingle |
Erwann P. Loret Albert Darque Elvenn A. Loret Corinne Nicolino-Brunet Sophie Morange Elisabeth Castagnier Josiane Casanova Christine Caloustian Charléric Bornet Julie Coussirou Jihen Bousseta Bertrand Dussol Isabelle Ravaux Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial Journal of Virus Eradication |
author_facet |
Erwann P. Loret Albert Darque Elvenn A. Loret Corinne Nicolino-Brunet Sophie Morange Elisabeth Castagnier Josiane Casanova Christine Caloustian Charléric Bornet Julie Coussirou Jihen Bousseta Bertrand Dussol Isabelle Ravaux |
author_sort |
Erwann P. Loret |
title |
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial |
title_short |
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial |
title_full |
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial |
title_fullStr |
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial |
title_full_unstemmed |
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial |
title_sort |
intradermal injection of a tat oyi-based therapeutic hiv vaccine significantly reduces levels of hiv rna and hiv dna rebound following art interruption in a phase i/ii randomized controlled clinical trial |
publisher |
Elsevier |
series |
Journal of Virus Eradication |
issn |
2055-6640 |
publishDate |
2016-05-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2055664020311857 |
work_keys_str_mv |
AT erwannploret intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT albertdarque intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT elvennaloret intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT corinnenicolinobrunet intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT sophiemorange intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT elisabethcastagnier intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT josianecasanova intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT christinecaloustian intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT charlericbornet intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT juliecoussirou intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT jihenbousseta intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT bertranddussol intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT isabelleravaux intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial |
_version_ |
1721479890330451968 |